AKT1 and Alzheimer disease: Western blot experiments revealed that in scopolamine-induced AD model mice, KSG could restore the normal levels of ERK/p-ERK by increasing the p-AKT/AKT ratio, which further indicated that KSG may exert anti-AD effects by regulating the PI3K-AKT and MAPK/ERK pathways.